Kadimastem plans listing on Nasdaq through merger
The Israeli biotech stem cell company will delist from the TASE.
Stay updated with breaking news from Tolerance Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Israeli biotech stem cell company will delist from the TASE.
Live presentation on Monday, January 8th at 11:30 AM PTMIAMI, FL / ACCESSWIRE / January 4, 2024 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage, privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced that Dr. Anthon...
ITolerance, Inc. and Kadimastem Ltd. Submit Initial Targeted Engagement ...
JTC Team Announces Presenting Company Line Up for the Virtual Investor ...
The 26th BioFlorida Annual Conference united 500+ statewide leaders from Florida's life sciences industry, representing biopharmaceutical, medical technology, digital health, and health systems, globally recognized research universities and research institutions, investors, policymakers, and economic development agencies, to spotlight the momentum and success in science, business, and public policy and spur collaboration and future global growth for Florida's companies.